<DOC>
	<DOCNO>NCT00482092</DOCNO>
	<brief_summary>Protocol 603 enrol subject moderate-to-severe Crohn 's disease intolerant , previously fail therapy , least one steroid least one immunosuppressant biologic monoclonal anti-body tumor necrosis factor alpha . The protocol investigate safety efficacy use PROCHYMAL® adult human stem cell induce remission . PROCHYMAL deliver vein arm four time two week , approximately hour time .</brief_summary>
	<brief_title>Evaluation PROCHYMAL® Adult Human Stem Cells Treatment-resistant Moderate-to-severe Crohn 's Disease</brief_title>
	<detailed_description>A significant number individual Crohn 's disease find relief exist steroidal , immunosuppressive , biologic therapy , force seek surgery drastic measure treatment . PROCHYMAL® adult human stem cell manufacture healthy , volunteer donor , extensively test , store available need . Human animal study show cell require donor-recipient matching . The cell may immunosuppressive heal benefit Crohn 's disease . The cell naturally migrate specifically sit inflammation , effect believe local self-limiting rather systemic . Protocol 603 enrol subject evaluate ability PROCHYMAL induce remission subject moderate-to-severe disease ( Crohn 's disease activity index -- CDAI -- 250 450 , inclusive ) fail intolerant least one drug steroid , immunosuppressant , biologic class .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>fail ( within last 2 yr ) intolerant least one steroid AND least one immunosuppressant AND EXACTLY one biologic CDAI 250 450 , inclusive endoscopically radiographically confirm Crohn 's disease ileus colon CRP least 5 mg/l ( 0.5 mg/dl ) *OR* CDAI least 300 weight 40 150 kg , inclusive adequate renal function negative PPD test ( evaluate low risk TB activation ) HIV hepatitis infection active allergy CT contrast agent , bovine porcine product symptomatic fibrostenotic Crohn 's disease permanent ostomy biologic therapy within past 90 prednisone great 20 mg/d within past month shortbowel syndrome total parenteral nutrition abnormal liver function malignancy active within past 5 year ( except completely resect basal squamous cell carcinoma skin ) enteric pathogen , include C. difficile history colonic mucosal dysplasia current prior evidence TB ( unless risk activation reactivation deem low )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Crohn 's disease</keyword>
	<keyword>adult stem cell therapy</keyword>
</DOC>